A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR a and PCK1

DSpace Repository

A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR a and PCK1

Author: Gallage, Suchira; Ali, Adnan; Avila, Jose Efren Barragan; Seymen, Nogayhan; Ramadori, Pierluigi; Joerke, Vera; Zizmare, Laimdota; Aicher, David; Gopalsamy, Indresh K.; Fong, Winnie; Kosla, Jan; Focaccia, Enrico; Li, Xin; Yousuf, Suhail; Sijmonsma, Tjeerd; Rahbari, Mohammad; Kommoss, Katharina S.; Billeter, Adrian; Prokosch, Sandra; Rothermel, Ulrike; Mueller, Florian; Hetzer, Jenny; Heide, Danijela; Schinkel, Benjamin; Machauer, Tim; Pichler, Bernd; Malek, Nisar P.; Longerich, Thomas; Roth, Susanne; Rose, Adam J.; Schwenck, Johannes; Trautwein, Christoph; Karimi, Mohammad M.; Heikenwalder, Mathias
Tübinger Autor(en):
Gallage, Suchira
Ramadori, Pierluigi
Joerke, Vera
Zizmare, Laimdota
Aicher, David
Gopalsamy, Indresh K.
Fong, Winnie
Schinkel, Benjamin
Pichler, Bernd
Trautwein, Christoph
Malek, Nisar Peter
Schwenck, Johannes Walter
Heikenwälder, Mathias
Published in: Cell Metabolism (2024), Bd. 36, H. 61371-1393.e7
Verlagsangabe: Cambridge : Cell Press
Language: English
Full text: http://dx.doi.org/10.1016/j.cmet.2024.04.015
ISSN: 1550-4131
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)